Cerebellar ataxia and epilepsy with anti-GAD antibodies: Treatment with IVIG and plasmapheresis

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Georgieva, Zoya ^a   Parton, Matthew ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893305163     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-202314     Document Type: Article

References (11)

1. Matthews B. Symptoms and signs of multiple sclerosis. In: Compston A, Ebers G, Lassman H, McDonald I, Matthews B, Wekerle H. eds. McAlpine's multiple sclerosis. 3rd edn. London: Churchill Livingston, 1998:145-90.
2. Abele M. The aetiology of sporadic adult-onset ataxia. Brain 2002;125:961-8. (Pubitemid 34464608)
3. Wenning GK. Clinical features and natural history of multiple system atrophy: a study of 100 cases. Brain 1994;117:835-45. (Pubitemid 24281844)
4. Raju R. Analysis of GAD65 autoantibodies in stiff person syndrome patients. J Immunol 2005;175:7755-62. (Pubitemid 41715229)
5. Honnorat J. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-30. (Pubitemid 32163159)
6. Takenoshita H. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 2001;70:386-9. (Pubitemid 32250898)
7. Rakocevic G. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff person syndrome: correlation with clinical severity. Arch Neurol 2004;61:902-4. (Pubitemid 38747330)
8. Nociti V. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neur 2010;17:e5.
9. Venhoff N. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study. Ann Rheum Dis 2009;68:1506-8.
10. Dalakas M. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol 2005;252(Suppl 1):I/19-25.
11. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al . Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-20. (Pubitemid 43964628)